Roche - Company Information
Roche Holding AG is a global pioneer in pharmaceuticals and diagnostics, specializing in personalized healthcare and innovative solutions for various ...Read more
Headquarters
Contact
Linkedin
Company Size10,000+
Stock SymbolN/A
Websiteroche.com
TypePublic
Roche Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by Roche
Roche Employee Profiles
Are you looking for the decision-makers at Roche? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover Roche’s employee details in less than 30 secs.
Sign-up for 6sense Revenue AI™ for Sales
To find emails, direct dials, and more for prospects across the web.
Sign Up TodayDownload the 6sense Chrome Extension to get verified contact data of Roche employees
Install Now
Roche News & Press Releases
Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are Roche latest news, alerts and updates.
Roche to Acquire LumiraDx Point-of-Care Testing Tech for up to $350M
Roche expects to integrate the POC clinical chemistry and immunoassay tests into its Diagnostics business when the acquisition closes in mid-2024.
2 Jan 2024
Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform
The transformative point of care solution will complement Roche‚ centralised diagnostics portfolio across Clinical Chemistry, Immunochemistry, Coagulation and Molecular, and across multiple disease areasLumiraDx‚ technology integrates multiple Point of Care tests on a simple to use single instrument and brings more affordable and accessible testing to patients worldwideUnder the terms of the agreement,
29 Dec 2023
Roche to acquire obesity drug maker Carmot Therapeutics for $2.7 billion
Pharmaceutical giant Roche said on Monday it has entered into a definitive agreement to acquire Carmot Therapeutics, a U.S. company with a research focus on obesity, for $2.7 billion. On top of the upfront purchase price of $2.
4 Dec 2023
Roche to Acquire Telavant for Up-to-$7.25B, Adding IBD Antibody
Roche is acquiring Telavant for up to $7.25 billion, in a deal designed to bolster its pipeline with an inflammatory bowel disease candidate.
23 Oct 2023
FAQs for Roche
Explore frequently asked questions about Roche’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.
Get instant access to B2B contact data across the web
Sign Up Today
